Evidence map›Paper›PMID 33025906›Full record

ArticleeLife2020

A versatile system to record cell-cell interactions.

Rui Tang, Christopher W Murray, Ian L Linde, Nicholas J Kramer, Zhonglin Lyu, Min K Tsai, Leo C Chen, Hongchen Cai, Aaron D Gitler, Edgar Engleman and 2 more

Abstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Synthetic living materials in cancer biology.Nature reviews bioengineering · 2023
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rui TangDepartment of Genetics, Stanford University School of Medicine, Stanford, United States.ORCID 0000-0002-6950-9580
Christopher W MurrayCancer Biology Program, Stanford University School of Medicine, Stanford, United States.ORCID 0000-0002-6551-2053
Ian L LindeImmunology Program, Stanford University School of Medicine, Stanford, United States.
Nicholas J KramerDepartment of Genetics, Stanford University School of Medicine, Stanford, United States.ORCID 0000-0003-4557-8343
Zhonglin LyuDepartment of Neurosurgery, Stanford University School of Medicine, Stanford, United States.
Min K TsaiDepartment of Genetics, Stanford University School of Medicine, Stanford, United States.
Leo C ChenDepartment of Genetics, Stanford University School of Medicine, Stanford, United States.ORCID 0000-0002-4950-0757
Hongchen CaiDepartment of Genetics, Stanford University School of Medicine, Stanford, United States.
Aaron D GitlerDepartment of Genetics, Stanford University School of Medicine, Stanford, United States.ORCID 0000-0001-8603-1526
Edgar EnglemanCancer Biology Program, Stanford University School of Medicine, Stanford, United States.ORCID 0000-0002-2096-9279
Wonjae LeeDepartment of Neurosurgery, Stanford University School of Medicine, Stanford, United States.
Monte M WinslowDepartment of Genetics, Stanford University School of Medicine, Stanford, United States.ORCID 0000-0002-5730-9573

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Vittorio Sebastiano · 2007 to 2026
$71.4M
Investigating molecular and cellular mechanisms of SCLC development to identify novel therapeutic strategiesR35CA231997 · NCI · STANFORD UNIVERSITY · PI SAGE, JULIEN · 2019 to 2025
$6.2M
Molecular dissection of Lkb1-mediated tumor suppressionR01CA230919 · NCI · STANFORD UNIVERSITY · PI WINSLOW, MONTE MEIER · 2018 to 2022
$2.1M
Molecular Dissection of Lung Cancer Progression and MetastasisR01CA175336 · NCI · STANFORD UNIVERSITY · PI WINSLOW, MONTE MEIER · 2013 to 2017
$1.7M
A Quantitative Multiplexed Platform for the Pharmacogenomic Analysis of Lung CancerR01CA207133 · NCI · STANFORD UNIVERSITY · PI PETROV, DMITRI, WINSLOW, MONTE MEIER · 2016 to 2018
$1.7M
OMX BLAZE High Speed Super Resolution Imaging SystemS10OD012276 · OD · STANFORD UNIVERSITY · PI STRAIGHT, AARON F · 2012 to 2012
$1.1M
Development of microfluidic blood-brain tumor barrier model to screen chemotherapeutic strategies for breast cancer brain metastasesK25CA201545 · NCI · STANFORD UNIVERSITY · PI LEE, WONJAE · 2017 to 2021
$786k
BD Canto II RUO CytometerS10RR027431 · NCRR · STANFORD UNIVERSITY · PI NOLAN, GARRY P · 2010 to 2010
$236k
Mechanistic basis of allogeneic IgG-induced tumor eradicationF31CA196029 · NCI · STANFORD UNIVERSITY · PI LINDE, IAN LISLE · 2015 to 2017
$127k
NCI NIH HHS F31 CA196029NCI NIH HHS K25 CA201545NCI NIH HHS P30 CA124435NCI NIH HHS R01 CA175336NCI NIH HHS R01 CA207133NCI NIH HHS R01 CA230919NCI NIH HHS R35 CA231997NCRR NIH HHS S10 RR027431NIH HHS CA196029NIH HHS S10 OD012276Tobacco-Related Disease Research Program 27FT-0044
6 · The paper itself

Abstract

Cell-cell interactions influence all aspects of development, homeostasis, and disease. In cancer, interactions between cancer cells and stromal cells play a major role in nearly every step of carcinogenesis. Thus, the ability to record cell-cell interactions would facilitate mechanistic delineation of the role of the cancer microenvironment. Here, we describe GFP-based Touching Nexus (G-baToN) which relies upon nanobody-directed fluorescent protein transfer to enable sensitive and specific labeling of cells after cell-cell interactions. G-baToN is a generalizable system that enables physical contact-based labeling between various human and mouse cell types, including endothelial cell-pericyte, neuron-astrocyte, and diverse cancer-stromal cell pairs. A suite of orthogonal baToN tools enables reciprocal cell-cell labeling, interaction-dependent cargo transfer, and the identification of higher order cell-cell interactions across a wide range of cell types. The ability to track physically interacting cells with these simple and sensitive systems will greatly accelerate our understanding of the outputs of cell-cell interactions in cancer as well as across many biological processes.

Indexed as

AnimalsCell CommunicationCell LineCoculture TechniquesGreen Fluorescent ProteinsHumansLentivirusMiceMicroscopyProtein TransportGreen Fluorescent Proteinscancer biologycancer-stromalcell biologycell-cell interactionhumanmousenanobodytumor microenvironment

Identifiers

PMID33025906
PMCPMC7682987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.